Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bff3c30d4a4dec7c1a4348ef8fc6cae5c> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bff3c30d4a4dec7c1a4348ef8fc6cae5c NCIT_P378 "NCI" @default.
- Bff3c30d4a4dec7c1a4348ef8fc6cae5c type Axiom @default.
- Bff3c30d4a4dec7c1a4348ef8fc6cae5c annotatedProperty IAO_0000115 @default.
- Bff3c30d4a4dec7c1a4348ef8fc6cae5c annotatedSource NCIT_C81058 @default.
- Bff3c30d4a4dec7c1a4348ef8fc6cae5c annotatedTarget "The anhydrous form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic resonance angiography (MRA) imaging. Gadofosveset is a stable gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) chelate derivative with a diphenylcyclohexylphosphate group. Upon injection, gadofosveset binds reversibly to endogenous serum albumin which increases its intravascular retention time compared to non-protein binding contrast agents. The serum albumin binding also increases T1-relaxivity of gadofosveset. This produces an increase in signal intensity of blood, thereby enhancing the visualization of blood vessels upon MRA and may aid in the diagnosis of certain blood vessels and heart disorders." @default.